A GROUNDBREAKING study has revealed that white button mushrooms (WBM) may reduce immune suppression and enhance anti-cancer immune responses in patients with prostate cancer. This research provides insights into WBM\u2019s potential as a nutraceutical intervention to slow PCa progression.<\/p>\n
In a dual-phase investigation, researchers studied the effects of WBM consumption on both murine models and patients participating in a Phase II clinical trial. The findings revealed significant reductions in the number and function of myeloid-derived suppressor cells (MDSCs), immune cells known to hinder the body\u2019s ability to fight cancer. These reductions were accompanied by increases in cytotoxic CD8+ T cells and natural killer (NK) cells, which are crucial for anti-tumor immunity.<\/p>\n
In preclinical mouse models, WBM treatment not only slowed tumor growth but also improved the efficacy of immune checkpoint inhibitors, specifically anti-PD-1 antibodies. This combination therapy resulted in enhanced tumor regression and improved survival outcomes, suggesting that WBM could act as an effective adjuvant to immunotherapy in prostate cancer management.<\/p>\n
The human arm of the study demonstrated similar immune-modulating effects. Patients treated with WBM for three months exhibited decreases in circulating polymorphonuclear MDSCs (PMN-MDSCs) and suppressed pro-tumor signaling pathways, including STAT3\/IRF1 and TGF\u03b2. Advanced single-cell profiling highlighted changes in the transcriptional profiles of PMN-MDSCs, pointing to reduced immune suppression and increased responsiveness to immune-stimulating signals.<\/p>\n
The research underscores WBM\u2019s potential to shift the immune environment in favor of anti-tumor activity. By targeting MDSCs and bolstering T cell and NK cell responses, WBM therapy offers a promising avenue for managing prostate cancer. While further studies are needed to confirm these findings, the integration of WBM into current treatment regimens could open new doors in cancer care.<\/p>\n
This study represents a step forward in understanding how natural compounds can complement existing therapies, offering hope for improved outcomes in patients with prostate cancer.<\/p>\n
Reference: Wang X et al. Reduction of myeloid-derived suppressor cells in prostate cancer murine models and patients following white button mushroom treatment. Clin Transl Med. 2024;e70048.<\/p>\n